Plasma Nervonic Acid Is a Potential Biomarker for Major Depressive Disorder: A Pilot Study

Abstract Background Diagnostic biomarkers of major depressive disorder, bipolar disorder, and schizophrenia are urgently needed, because none are currently available. Methods We performed a comprehensive metabolome analysis of plasma samples from drug-free patients with major depressive disorder (n=9), bipolar disorder (n=6), schizophrenia (n=17), and matched healthy controls (n=19) (cohort 1) using liquid chromatography time-of-flight mass spectrometry. A significant effect of diagnosis was found for 2 metabolites: nervonic acid and cortisone, with nervonic acid being the most significantly altered. The reproducibility of the results and effects of psychotropic medication on nervonic acid were verified in cohort 2, an independent sample set of medicated patients [major depressive disorder (n=45), bipolar disorder (n=71), schizophrenia (n=115)], and controls (n=90) using gas chromatography time-of-flight mass spectrometry. Results The increased levels of nervonic acid in patients with major depressive disorder compared with controls and patients with bipolar disorder in cohort 1 were replicated in the independent sample set (cohort 2). In cohort 2, plasma nervonic acid levels were also increased in the patients with major depressive disorder compared with the patients with schizophrenia. In cohort 2, nervonic acid levels were increased in the depressive state in patients with major depressive disorder compared with the levels in the remission state in patients with major depressive disorder and the depressive state in patients with bipolar disorder. Conclusion These results suggested that plasma nervonic acid is a good candidate biomarker for the depressive state of major depressive disorder.

[1]  Steven A. Brown,et al.  The human circadian metabolome , 2012, Proceedings of the National Academy of Sciences.

[2]  J. Kornhuber,et al.  A central role for the acid sphingomyelinase/ceramide system in neurogenesis and major depression , 2015, Journal of neurochemistry.

[3]  M. Keshavan,et al.  Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline. , 2004, Schizophrenia bulletin.

[4]  Godfrey D Pearlson,et al.  Diffusion tensor imaging white matter endophenotypes in patients with schizophrenia or psychotic bipolar disorder and their relatives. , 2013, The American journal of psychiatry.

[5]  K Nobuhara,et al.  Frontal white matter anisotropy and symptom severity of late-life depression: a magnetic resonance diffusion tensor imaging study , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  Neil M. Johannsen,et al.  Blood fatty acid changes in healthy young Americans in response to a 10-week diet that increased n-3 and reduced n-6 fatty acid consumption: a randomised controlled trial. , 2017, The British journal of nutrition.

[7]  R. C. Young,et al.  A Rating Scale for Mania: Reliability, Validity and Sensitivity , 1978, British Journal of Psychiatry.

[8]  G. Asnis,et al.  Cortisol secretion in endogenous depression. I. Basal plasma levels. , 1985, Archives of general psychiatry.

[9]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[10]  M. Obermeier.  The positive and negative syndrome scale for schizophrenia , 2012 .

[11]  A. Altamura,et al.  Misdiagnosis, duration of untreated illness (DUI) and outcome in bipolar patients with psychotic symptoms: A naturalistic study. , 2015, Journal of affective disorders.

[12]  T. Suppes,et al.  Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. , 2010, The Journal of clinical psychiatry.

[13]  I. Mougan,et al.  Fatty Acid Composition of Human Brain Phospholipids During Normal Development , 1998, Journal of neurochemistry.

[14]  J. Kornhuber,et al.  Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs , 2013, Nature Medicine.

[15]  S. Smesny,et al.  Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 Study , 2016, PloS one.

[16]  M. Milburn,et al.  Analysis of the adult human plasma metabolome. , 2008, Pharmacogenomics.

[17]  I. Heuser,et al.  Increased diurnal plasma concentrations of cortisone in depressed patients. , 2000, The Journal of clinical endocrinology and metabolism.

[18]  A. Altamura,et al.  Biological aspects and candidate biomarkers for psychotic bipolar disorder: A systematic review , 2016, Psychiatry and clinical neurosciences.

[19]  Janet B W Williams.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[20]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[21]  H. Hara,et al.  Proportion of nervonic acid in serum lipids is associated with serum plasmalogen levels and metabolic syndrome. , 2014, Journal of oleo science.

[22]  J. Lake,et al.  Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. , 2006, The Journal of clinical psychiatry.

[23]  F. Pouwer,et al.  Plasma and Erythrocyte Fatty Acid Patterns in Patients with Recurrent Depression: A Matched Case-Control Study , 2010, PloS one.

[24]  Isidre Ferrer,et al.  Metabolomics of human brain aging and age-related neurodegenerative diseases. , 2014, Journal of neuropathology and experimental neurology.

[25]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[26]  W. Gaebel,et al.  Schizophrenia in 2020: Trends in diagnosis and therapy , 2015, Psychiatry and clinical neurosciences.

[27]  C. Ramchand,et al.  Polyunsaturated fatty acid levels in red cell membranes of unmedicated schizophrenic patients , 2004, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[28]  R. Yolken,et al.  Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder , 2000, Molecular Psychiatry.

[29]  R. Zhu,et al.  Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naïve schizophrenia patients after treatment with risperidone. , 2012, Journal of proteome research.

[30]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[31]  Edgar Erdfelder,et al.  G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences , 2007, Behavior research methods.

[32]  K. Tessner,et al.  Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. , 2008, Annual review of clinical psychology.

[33]  James McKirdy,et al.  White matter abnormalities in bipolar disorder and schizophrenia detected using diffusion tensor magnetic resonance imaging. , 2009, Bipolar disorders.

[34]  P. McGorry,et al.  Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study , 2015, Nature Communications.

[35]  A. Hayashi‐Takagi,et al.  Peripheral Biomarkers Revisited: Integrative Profiling of Peripheral Samples for Psychiatric Research , 2014, Biological Psychiatry.

[36]  J. Lieberman,et al.  Neuroactive Steroids are Altered in Schizophrenia and Bipolar Disorder: Relevance to Pathophysiology and Therapeutics , 2006, Neuropsychopharmacology.

[37]  C W Turck,et al.  Metabolite profiling of antidepressant drug action reveals novel drug targets beyond monoamine elevation , 2011, Translational Psychiatry.

[38]  H. Kunugi,et al.  Biochemical markers subtyping major depressive disorder , 2015, Psychiatry and clinical neurosciences.

[39]  Shih-Yi Huang,et al.  Polyunsaturated fatty acid deficit in patients with bipolar mania , 2003, European Neuropsychopharmacology.

[40]  S. Rapoport,et al.  Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute mania. , 2007, Bipolar disorders.

[41]  T. Whitford,et al.  Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals , 2012, Molecular Psychiatry.

[42]  E. Etxeberria,et al.  Metabolomic analysis in food science: a review , 2009 .

[43]  M. Leboyer,et al.  Duration of untreated bipolar disorder: missed opportunities on the long road to optimal treatment , 2013, Acta psychiatrica Scandinavica.

[44]  Shih-Yi Huang,et al.  A Meta-Analytic Review of Polyunsaturated Fatty Acid Compositions in Patients with Depression , 2010, Biological Psychiatry.

[45]  Jun Liu,et al.  Prefrontal white matter abnormalities in young adult with major depressive disorder: A diffusion tensor imaging study , 2007, Brain Research.

[46]  H. Moser,et al.  Adrenoleukodystrophy , 1998, Neurology.

[47]  N. Rose,et al.  Biomarkers in psychiatry , 2009, Nature.

[48]  E. Dennis,et al.  High sensitivity quantitative lipidomics analysis of fatty acids in biological samples by gas chromatography-mass spectrometry. , 2011, Biochimica et biophysica acta.

[49]  Mark M. Rasenick,et al.  Lipid raft microdomains and neurotransmitter signalling , 2007, Nature Reviews Neuroscience.